Amgen Inc (AMGN)

236.74 +0.75  +0.32% NASDAQ Dec 13, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/13/2020 Dividends Amount: 1.60, Declared Date: Dec 11 2019, Pay Date: Mar 06 2020
01/29/2020 14:00 PST Misc Amgen Inc Fourth Quarter Earnings Conference Call in 2019
01/29/2020 Earnings Amgen Inc Fourth Quarter Earnings in 2019 Release
11/14/2019 Dividends Amount: 1.45, Declared Date: Oct 22 2019, Pay Date: Dec 06 2019
10/29/2019 14:00 PDT Misc Amgen Inc Third Quarter Earnings Conference Call for 2019
10/29/2019 Earnings Amgen Inc Third Quarter Earnings in 2019 Release
08/14/2019 Dividends Amount: 1.45, Declared Date: Aug 02 2019, Pay Date: Sep 06 2019
07/30/2019 17:00 EDT Misc Amgen Inc Second Quarter Earnings Conference Call in 2019
07/30/2019 Earnings Amgen Inc Second Quarter Earnings in 2019 Release
05/21/2019 11:00 EDT Misc Amgen Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.amgen.com
  • Investor Relations URL: http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Jan. 29, 2020
  • Last Earnings Release: Oct. 29, 2019
  • Next Ex-Dividend Date: Feb. 13, 2020
  • Last Ex-Dividend Date: Nov. 14, 2019
  • Description: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).

Top Fund Holders

Symbol Name Weighting
IBB iShares Nasdaq Biotechnology ETF 8.43%
XLV Health Care Select Sector SPDR® ETF 3.79%
VPMCX Vanguard PRIMECAP Inv 3.16%
RMEBX American Funds American Mutual R2E 1.91%
QQQ Invesco QQQ Trust 1.56%
RICHX American Funds Invmt Co of Amer R5E 1.54%
RIRHX American Funds Capital Income Bldr R5E 1.53%
VYM Vanguard High Dividend Yield ETF 1.24%
CWGCX American Funds Capital World Gr&Inc C 1.04%
VTV Vanguard Value ETF 1.03%
IWF iShares Russell 1000 Growth ETF 0.87%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.